The pathological basis of intestinal microecology in the damp-heat syndrome of non-alcoholic fatty liver disease

Shuguang Hospital affiliated with Shanghai University of TCM0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•Eligible patients with chronic liver diseases included those who were diagnosed with CHB or NAFLD, were 18–65 years of age, and signed an informed consent form.

•Those who were diagnosed with other chronic liver diseases such as other viral hepatitis, alcoholic fatty liver disease, cirrhosis, liver cancer, and NAFLD co-infected with HBV were excluded. Those with serious primary disease or malignant tumor, who had undergone gastrointestinal bariatric surgery or taken weight loss drugs within the past three months, who had undergone gastrointestinal bariatric surgery in the past year or who had taken weight-loss drugs in the past 3 months and had lost more than 10% of their body weight, who had taken antibiotics or proton pump inhibitors within the past month, or were pregnant or lactating were also excluded. Healthy controls were defined as individuals with normal routine laboratory tests, no diagnosis of chronic liver disease, and no abnormal TCM symptoms.

发起方

Shuguang Hospital affiliated with Shanghai University of TCM